Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

PrEP implants are promising for HIV prevention if the number of implants needed is minimized.

The study identifies four distinct zones in the fetal vaginal epithelium, enhancing understanding for potential applications in women's health.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Melatonin improved sheep reproduction, being more beneficial and cost-effective in males.

HAIR may cause fetal loss by triggering different cell death processes in the uterus and placenta.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Including ovarian morphology in diagnosis increases PCOS prevalence estimates, highlighting the need for standardized criteria.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

Cell-free fat extract may boost IVF success in older women with past failures.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

17β-Estradiol boosts allergic reactions and slows thymus aging in mice.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Females with idiopathic hirsutism have higher levels of omentin-1, which may lead to excessive hair growth.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Metformin improved menstrual cycles and cholesterol but didn't change weight or hormone levels in the short term for overweight PCOS women.

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

The conclusion is that there's a need for a new conference to establish stricter guidelines for diagnosing Polycystic Ovary Syndrome (PCOS).

PCOS management includes lifestyle changes and medications to improve fertility.

Estrogen receptors affect hair growth, with ER beta slowing down the hair cycle changes caused by ER alpha.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.